LUNG Pulmonx Corp

8-K Current Report

Filed: March 4, 2026

Health Care

Surgical & Medical Instruments & Apparatus

Pulmonx Corp (LUNG) 8-K current report filed with SEC EDGAR on March 4, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 and full-year 2025 results announced March 4, 2026 — full figures in Exhibit 99.1
• Pulmonx (LUNG) is a small-cap medical device company focused on bronchoscopic lung volume reduction treatments

Other Pulmonx Corp 8-K Filings

8-K Mar 5, 2026

Get deeper insights on Pulmonx Corp

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.